FACTORx specializes in using national-scope medical claims data to measure the impact of CME activities and the performance of the CME participants. We have established partnerships with several data aggregators and a data analyst who brings more than 20 years of claims experience to every project we work on to help ensure that the data is analyzed and reported in the correct manner. 

We offer the following services to our Academic, Institutional and Medical Education Company partners. Please contact us to see how we can help with your next big CME initiative.


  • Audience Identification
  • Audience Generation
  • Educational Gap Verification
  • Performance Improvement (pre/post intervention as compared to control groups)
  • Potential Patient Impact Factor Analysis

Performance Improvement Type Initiatives

Topic: Rheumatoid Arthritis

Target Audience: Primary Care Providers (National audience)

Curriculum: Multi-platform based curriculum focused on the benefits of an early diagnosis, appropriate referral to a specialist and long-term co-management strategies.

Proposed Measure: To measure the referral trends amongst CME participants 4 months, pre/post intervention and compare them against a control group.

Outcome: Of the 531 CME participants for whom we were able to match against the national-scope medical claims database, we were able to identify a relative 11.8% increase in the number of referrals they made 4 months post-intervention, compared to no increase/decrease observed in the control group.

If you’re familiar with claims data, you know it’s almost impossible to track an actual referral……Contact us to find out how we did it.

Audience Identification / Generation / Performance Improvement  Outcomes 

Topic: Rheumatoid Arthritis

Target Audience: Primary Care Providers who diagnose and refer at the lowest frequency (under-performers)

Claims Database Selection Criteria: Primary Care Provider, <7 Dx of RA over last 14 months, fewest # of shared patients (referral rates), high % of female patients ages 25-55 and/or male patients 50-55, none of whom have been diagnosed with RA

Output:  Identified 61,382 primary care providers who currently managed/treated 17,748,309 patients living at higher risk for RA.

Outcome: 1,691 of our CME participants currently manage/treat 265,834 of the 17,748,309 patient pool identified in our baseline analysis, yielding 1,837 newly diagnosed RA patients 2.5+ years post-activity.

Contact us for more information on how we reached the 61,382 clinicians identified as being in the best position to impact patient care.


Supplemental Audience Generation/Potential Patient Impact Factor Results

Topic: Hypertension

Target Audience: Primary Care Providers who treat hypertension patients

Supplemental Audience Generation E-mail Campaign Selection Criteria: Identify the 10,000 primary care providers, who are in the best position to impact patient care based on specific prescription and patient profile criteria.

Outcome: A small percentage of learners from our supplemental audience generation campaign completed the CME activity for certification, those clinicians managed/treated more than 96,661 patients who had already been diagnosed with hypertension and been prescribed a hypertensive agent.

Contact us to find out how many learners manage 96,661 hypertension patients, we think you’ll be surprised.

Potential Patient Impact Factor Analysis

Objective: Determine how many OAB patients who had been previously diagnosed and been prescribed an appropriate medication are currently being treated by the participants of a CME initiative.

Methodology: There were 2,324 participants for the live and enduring CME activities who stated they would commit to a positive practice change or that their practice patterns were already consistent with the curriculum. 2,002 (86% match rate) of whom we were able to match against the national scope medical claims database. Through an analysis of ICD-9 codes and prescription data, we were able to determine how many patients with OAB these 2,002 clinicians currently manage/treat to objectively determine the minimum number of patients who would potentially be impacted by these CME interventions. Of the 2,002 providers, 1,004 were currently managing/treating OAB patients and had written at least one prescription for an OAB medication in the last twelve months.

Outcome: Based on an analysis of the medical claims database, we were able to identify 1,004 (out of 2,002) primary care providers who currently manage/treat 6,403 validated OAB patients or an average of 6.38 OAB patients/provider.

If you’d like to know how these numbers stack up against the national average, please contact us.

Steve Bender, President
Office: +1.856.795.9264
Mobile: +1.484.354.4816